Plus   Neg

Pre-market Movers For Feb 11 (L, GOOG, CELG, WEN, RDN)


Celgene Corp. (CELG) is rising more than 1 percent to $101.80. The company announced that Revlimid has been granted approval for the treatment of patients with relapsed or refractory multiple myeloma in China. The company also informed that its application for Revlimid in patients with relapsed or refractory mantle cell lymphoma after prior therapy that included bortezomib has been accepted by the FDA.

Wendy's Co. (WEN) is rising over 3 percent to $5.20.


Loews Corp. (L) is down 3 percent to $42.50. The company slipped to a loss in its fourth quarter, hurt mainly by Storm Sandy-related catastrophe losses at its 90 percent owned property and casualty insurance unit CNA Financial Corp. (CNA) and lower results at 50.4 percent-owned unit Diamond Offshore Drilling, Inc. (DO). Meanwhile, revenues for the quarter improved from the prior year period.

Google Inc. (GOOG) is down nearly 1 percent to $779.00. The company disclosed on Friday that executive chairman Eric Schmidt plans to sell up to about 3.2 million shares of the company's Class A common stock over a period of one year pursuant to a pre-arranged trading plan adopted in November. At Friday's closing price of $785.37, the shares being sold would fetch about $2.5 billion.

Radian Group Inc. (RDN) is falling 7 percent to $6.25. The company's fourth quarter loss widened from the year-ago quarter. Net premiums written and net premiums earned by its insurance business improved from the prior year period. Total revenues for the quarter declined from the same period a year earlier.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT